307 related articles for article (PubMed ID: 22870897)
1. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P; Doherty TM; Hailu A; Aseffa A
BMC Res Notes; 2012 Aug; 5():415. PubMed ID: 22870897
[TBL] [Abstract][Full Text] [Related]
2. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
[TBL] [Abstract][Full Text] [Related]
3. Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers.
de Souza FM; do Prado TN; Pinheiro Jdos S; Peres RL; Lacerda TC; Loureiro RB; Carvalho JA; Fregona G; Dias ES; Cosme LB; Rodrigues RR; Riley LW; Maciel EL
PLoS One; 2014; 9(8):e102773. PubMed ID: 25137040
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
5. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
[TBL] [Abstract][Full Text] [Related]
6. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
[TBL] [Abstract][Full Text] [Related]
8. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
[TBL] [Abstract][Full Text] [Related]
9. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
Sabri A; Quistrebert J; Naji Amrani H; Abid A; Zegmout A; Abderrhamani Ghorfi I; Souhi H; Boucaid A; Benali A; Abilkassem R; Kmari M; Hassani A; Lahcen B; Siah S; Schurr E; Boisson-Dupuis S; Casanova JL; Lahlou A; Laatiris A; Louzi L; Ouarssani A; Bourazza A; Aouragh A; Mustapha B; Messaoudi N; Agader A; Cobat A; Abel L; El Baghdadi J
PLoS One; 2019; 14(8):e0221081. PubMed ID: 31415649
[TBL] [Abstract][Full Text] [Related]
13. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
[TBL] [Abstract][Full Text] [Related]
14. QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
Muñoz L; Gonzalez L; Soldevila L; Dorca J; Alcaide F; Santin M
PLoS One; 2017; 12(8):e0183258. PubMed ID: 28854216
[TBL] [Abstract][Full Text] [Related]
15. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.
Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G
New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443
[TBL] [Abstract][Full Text] [Related]
16. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
17. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
[TBL] [Abstract][Full Text] [Related]
18. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
[TBL] [Abstract][Full Text] [Related]
19. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
